DMRA
Damora Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.33
-0.04 ▼ -0.15%
🌙 3월 13일 5:25 PM ET (한국 3/14 06:25)
$26.10
-0.23 ▼ -0.87%
| Index | - | P/E | - | EPS (ttm) | -12.1 | Insider Own | 7.63% | Shs Outstand | 0.06B | Perf Week | -8.92% |
| Market Cap | 1.59B | Forward P/E | - | EPS next Y | -11.96% | Insider Trans | -0.02% | Shs Float | 0.06B | Perf Month | 20.78% |
| Enterprise Value | 1.58B | PEG | - | EPS next Q | -0.11 | Inst Own | 16.19% | Short Float | 0.5% | Perf Quarter | -10.59% |
| Income | -0.02B | P/S | - | EPS this Y | 94.84% | Inst Trans | 1.75% | Short Ratio | 1.49 | Perf Half Y | 840.36% |
| Sales | 0.00B | P/B | 5.24 | EPS next 5Y | 56.9% | ROA | -92.89% | Short Interest | 0.28M | Perf YTD | 14.43% |
| Book/sh | 5.02 | P/C | 208.43 | EPS past 3/5Y | 28.75% 14.83% | ROE | -114.81% | 52W High | -31.3% ($38.33) | Perf Year | 563.22% |
| Cash/sh | 0.13 | P/FCF | - | Sales past 3/5Y | - | ROIC | -196.48% | 52W Low | 1209.95% ($2.01) | Perf 3Y | -46.54% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.42% | Gross Margin | - | Volatility(W/M) | 15.78% 12% | Perf 5Y | -88.84% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.73 | EPS Q/Q | 30.38% | Profit Margin | - | RSI (14) | 45.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.73 | Sales Q/Q | - | SMA20 | -9.45% ($29.08) | Beta | 1.6 | Target Price | $46.75 |
| Payout | - | Debt/Eq | 0.21 | Earnings | 11000000 | SMA50 | 0.49% ($26.2) | Rel Volume | 0.98 | Prev Close | $26.37 |
| Employees | 5 | LT Debt/Eq | 0.21 | EPS/Sales Surpr. | - | SMA200 | 95.6% ($13.46) | Avg Volume(3M) | 0.19M | Price | $26.33 |
| IPO | 2020/10/29 | Option/Short | No/Yes | Trades | 2904 | Volume | 181,695 | Change | -0.15% |
뉴스 로딩 중...